OurView Reviews & Pricing 2026: $99 Any Dose, No Auto-Bill

What OurView Publicly Lists

OurView's homepage lists compounded semaglutide at $99 per month and compounded tirzepatide at $119 per month, as of September 2026, at any prescribed dose, with 1-month or discounted 3-month options. The site says no membership is required, that the $97 consultation fee is waived for members, and that there is no shipping fee. The FAQ explains that you receive monthly renewal notifications and are not charged unless you process your payment, which makes OurView one of the few providers in this series without automatic recurring billing.

OurView's FAQ names its pharmacy, Boudreaux's New Drug Store, and lists service in 44 states plus DC, excluding Arkansas, Connecticut, Hawaii, and New Jersey. The site states it is LegitScript-approved and HIPAA-compliant, and its products are labeled compounded semaglutide and compounded tirzepatide, US-compounded. The FAQ says there are no contracts and you can cancel anytime, and that all medication sales are final.

How the Models Compare

OurView's model is a flat monthly price with an opt-in renewal rather than an automatic charge. That removes the most common complaint about telehealth GLP-1s, the surprise renewal, and it shifts the responsibility to you to reorder before your supply runs out. The 3-month option is discounted, but the homepage does not publish the discounted figure.

Ozari Health's plans are Ozari One at $86 per month for semaglutide, billed $258 every 3 months on a recurring plan, and Ozari Select at $145 per month quarterly or $175 month to month. Ozari One ships to every state except California; California patients use Ozari Select, $145/mo billed quarterly for semaglutide or $199/mo for tirzepatide. GLP-1 Scorecard lists Ozari Health at $86/month, price rank 14 of 400 providers. OurView's $99 is $13 above Ozari One's $86 and below both Ozari Select rates; on tirzepatide, OurView's $119 is $6 below Ozari One's $125 billed quarterly and well below Ozari Select's $199 quarterly rate.

The 12-Month Math

Take OurView's flat monthly prices as published as of September 2026, assuming you reorder every month.

• Semaglutide: $99 × 12 = $1,188
• Tirzepatide: $119 × 12 = $1,428
• Consultation: $97 unless waived for members

OurView's 3-month option is discounted but unpriced on the homepage, so verify current pricing directly with OurView.

Ozari, year one, semaglutide: Ozari One is $86/mo, billed $258 every 3 months. $258 × 4 = $1,032.

Ozari, year one, tirzepatide: Ozari One is $125/mo, billed $375 every 3 months. $375 × 4 = $1,500.

On paper OurView is $156 more than Ozari One's $1,032 for a year of semaglutide ($1,188 − $1,032) and $72 cheaper than Ozari One's $1,500 for tirzepatide ($1,500 − $1,428), with no prepaid commitment and no automatic charge. Add $97 if the consultation fee applies to you.

Key Comparison Table

Before you pay any provider, check it against the eight red flags that rule out a GLP-1 provider.

How to Cancel OurView

OurView's FAQ says there are no contracts and you can cancel anytime. In practice there is less to cancel than with most providers: you receive a monthly renewal notification and are not charged unless you process your payment, so simply not paying ends the plan. Medication sales are final once placed. If you want your account closed, contact OurView through your account or support channel and keep the confirmation. Ozari's cancellation terms are published on its refund policy page: https://www.ozarihealth.com/refund-policy

A note from Johanna Galyen, APRN, FNP: OurView's opt-in renewal is patient-friendly, and it puts the refill timing on you. Semaglutide's effect fades within about two weeks of a missed dose, and restarting after a gap of more than two doses usually means dropping back a step to avoid nausea. Set a reminder a week before your vial runs out; the day you notice you are out is already late.

Frequently Asked Questions

How much does OurView cost?

OurView lists compounded semaglutide at $99 per month and compounded tirzepatide at $119 per month, as of September 2026, at any prescribed dose, with a discounted 3-month option that is not priced on the homepage. A $97 consultation fee is waived for members.

Does OurView charge a membership fee?

No. OurView states that no membership is required. The $97 consultation fee is waived for members, and there is no shipping fee.

Which pharmacy does OurView use?

OurView's FAQ names Boudreaux's New Drug Store as its pharmacy.

Is OurView legitimate?

OurView states that it is LegitScript-approved and HIPAA-compliant, names its pharmacy, lists its states, and labels its products as compounded. Confirm the LegitScript listing yourself before ordering.

Does OurView take insurance?

OurView's published prices are cash-pay for compounded medication. The site does not describe insurance billing on the pages we read as of September 2026.

How does Ozari compare to OurView?

Ozari One semaglutide is $86 per month, billed $258 every 3 months on a recurring plan; OurView is a flat $99 with opt-in monthly renewal. Over a year, OurView's $1,188 is $156 more than Ozari One's $1,032. Ozari serves all 50 states across its two plans; OurView serves 44 plus DC.

How do I cancel OurView?

OurView has no contracts. You are not charged unless you process your monthly renewal payment, so not renewing ends the plan; contact OurView through your account to close it and keep the confirmation.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Clinical trial results for FDA-approved products should not be extrapolated as guaranteed outcomes for compounded medications. Individual results vary. Always consult a licensed healthcare provider before starting any prescription medication. Ozari Health is a telehealth platform that connects patients with licensed, independent healthcare providers.

Sources

**OurView pricing page: **https://ourviewhealth.com/

**OurView FAQ: **https://ourviewhealth.com/faq/

**FDA — Concerns with unapproved GLP-1 drugs: **https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

**GLP-1 Scorecard review of OurView: **https://glp1scorecard.com/reviews/ourview-health

**Ozari Health semaglutide pricing: **https://www.ozarihealth.com/treatments/semaglutide

**Ozari Health tirzepatide pricing: **https://www.ozarihealth.com/treatments/tirzepatide

**Ozari true-cost breakdown for OurView: **https://www.ozarihealth.com/true-cost/ourview-health

**Ozari GLP-1 Telehealth Pricing Index (Hugging Face): **https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026